Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages
Carmen G. Palii(Ottawa Hospital), Marjorie Brand(University of Wisconsin System), Fengtao Dai(University of Ottawa), Harold Atkins(University of Ottawa), Yi Cao(Guizhou Academy of Sciences), Robert Gentleman(Dana-Farber Cancer Institute), Zizhen Yao(Allen Institute for Brain Science), F. Jeffrey Dilworth(University of Ottawa), David Allan(University of Ottawa), Jerry Davison(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carolina Perez‐Iratxeta, Stephen J. Tapscott(University of Washington)
Cited by 142
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419